tiprankstipranks
Advertisement
Advertisement
Johnson & Johnson to acquire Firefly Bio for $1B in cash
PremiumThe FlyJohnson & Johnson to acquire Firefly Bio for $1B in cash
5d ago
Johnson & Johnson Rival Medline Rocked by FDA Crackdown
Premium
Weekend Updates
Johnson & Johnson Rival Medline Rocked by FDA Crackdown
6d ago
Best ETFs to Invest In, According to AI Analyst, 6/5/2026
Premium
Market News
Best ETFs to Invest In, According to AI Analyst, 6/5/2026
7d ago
Johnson & Johnson presents exploratory analyses from DAHLIAS study
PremiumThe FlyJohnson & Johnson presents exploratory analyses from DAHLIAS study
10d ago
Johnson & Johnson announces nipocalimab met primary endpoint in JASMINE study
Premium
The Fly
Johnson & Johnson announces nipocalimab met primary endpoint in JASMINE study
10d ago
Medline Stock (MDLN) Sinks on FDA Warning over Production Practices
Premium
Market News
Medline Stock (MDLN) Sinks on FDA Warning over Production Practices
10d ago
J&J reports updated results from Phase 1/1b CHRYSALIS-2 study
PremiumThe FlyJ&J reports updated results from Phase 1/1b CHRYSALIS-2 study
14d ago
Johnson & Johnson reports new data from Phase 3 MajesTEC-9 study
Premium
The Fly
Johnson & Johnson reports new data from Phase 3 MajesTEC-9 study
15d ago
J&J says FDA approves Tremfya label expansion
Premium
The Fly
J&J says FDA approves Tremfya label expansion
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100